SMARCA1 and leukemia: The expression of the same constructs used for knockdown in transformed MLL-AF9 cells were unable to cause a proliferation defect on primary c-Kit-enriched bone marrow cells in culture, suggesting a leukaemia-specific requirement of these SWI/SNF complex components (Fig 1F).